Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients.

This study was performed with the aim of discovering the characteristics and survival of patients with metastatic renal carcinoma who undergo immunotherapy with an Interleukin 2 based regimen. One hundred and eighty-one patients with metastatic renal carcinoma were referred to our institute from Oct...

Descripción completa

Detalles Bibliográficos
Autores principales: Philip, T., Negrier, S., Lasset, C., Coronel, B., Bret, M., Blay, J. Y., Merrouche, Y., Carrie, C., Kaemmerlen, P., Chauvin, F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968726/
https://www.ncbi.nlm.nih.gov/pubmed/8217594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968726/
https://www.ncbi.nlm.nih.gov/pubmed/8217594

Ejemplares similares